Ultivue Lands $5,150,000 Series A Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=6cc80898-3004-4645-bda0-bdb018c73bfa - Date
10/14/2015 - Company Name
Ultivue - Mailing Address
763D Concord Avenue Cambridge, MA 02138 USA - Company Description
Ultivue is an early stage life sciences tools company that seeks to provide the ultimate view into biology. Ultivue produces reagents that enable researchers to obtain microscopic images at an unprecedented resolution that vastly improve our understanding of biology and medicine. - Website
http://www.ultivue.com - Transaction Type
Venture Equity - Transaction Amount
$5,150,000 - Transaction Round
Series A - Proceeds Purposes
In addition to the Series A funding, Ultivue has received an exclusive license from Harvard University for the Wyss Institute’s DNA-PAINT and DNA-Exchange technologies and acquired the rights to other key enabling technology from California Institute of Technology. - M&A Terms
- Venture Investor
ARCH Venture Partners - Venture Investor
Investor - Venture Investor
Undisclosed
